GlassScriptPhysician profile
Forozan Navid
NPI 1790842912
$5,604.88
in general payments reported to CMS, 2019-2025
13 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.43 · 2021: $74.66 · 2022: $143 · 2023: $5,133 · 2024: $90.50 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,912 · Food and Beverage: $1,443 · Honoraria: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,911.51 |
| Food and Beverage | $1,442.72 |
| Honoraria | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,562.35 | 2023-2025 | Endurant Iis, Corevalve Evolut R |
| Philips North America LLC | $2,470.02 | 2023 | (9520) Igt Devices Undivided, (6554) Periph Vasc Undiv, (9281) Turbo Elite |
| Abbott Laboratories | $195.91 | 2021-2022 | |
| Next Science LLC | $128.50 | 2023 | Surgx, Blastx, Xperience |
| Edwards Lifesciences Corporation | $78.45 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.79 | 2023-2024 | Lifevest |
| Davol INC. | $33.43 | 2019 | |
| Abiomed | $21.31 | 2022 | |
| Bard Peripheral Vascular, INC. | $17.76 | 2023 | Rotarexs 6 F X 135 Cm |
| Amgen INC. | $16.20 | 2023 | Repatha |
| Astrazeneca Pharmaceuticals LP | $14.82 | 2025 | Lokelma |
| Merck Sharp & Dohme LLC | $14.22 | 2023 | Verquvo |
| Janssen Pharmaceuticals, INC | $14.12 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Forozan Navid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.